The cannabis penny stocks market is standing tall today and in the face of adversity! Looking at the index, most of our penny stocks are in the green. And this is despite cannabis’ biggest names being in the red.
Canada’s Big Four vs. Cannabis Penny Stocks
We’ll be looking at Aurora Cannabis compared to Namaste Technologies; Canopy Growth against Liberty Health Sciences; Tilray against The Green Organic Dutchman; and Aphria against Isodiol International.
Aurora Cannabis vs. Namaste Technologies
Batting first for Canada’s Big Four is Aurora Cannabis (TSX:ACB) (NYSE:ACB). With a market cap of $8.8 billion, these shares are disappointedly down -0.22%, selling for $9.18—down despite Aurora’s very recent uplisting to the NYSE.
What a shame.
On the flip side, Namaste Technologies (TSXV:N) is a cannabis penny stocks company with a market cap of $556 million. These shares are up 1.12% and selling for $1.81 at the time of writing.
Canopy Growth Corp vs. Liberty Health Sciences
Up next for Canada’s Big Four, Canopy Growth Corp (TSX:WEED) (NYSE:CGC) is down -0.08% and is selling for $37.11. Canopy has a market cap of $8.6 billion, which is far greater than its cannabis penny stock competitor Liberty Health Sciences (CSE:LHS).
LHS’s market cap is a paltry $500 million by comparison.
However, Liberty’s game is stronger today; with gains of 5.04%, this stock is selling for $1.46.
Tilray vs. The Green Organic Dutchman
The big dog for the Big Four is, of course, Tilray (NASDAQ:TLRY), the stock that saw the most gains of any cannabis company this year. With a market cap just shy of $9 billion, Tilray is Canada’s biggest cannabis company. However, even TLRY is in the red today. Selling for $96.16, these stocks are down -3.35%.
But giving everyone a run for their money is the underdog, The Green Organic Dutchman (TSX:TGOD). Our biggest cannabis penny stock gainer on the market today, TGOD is up 18.91% and selling for $4.15.
Aphria vs. Isodiol International
And our final player for Canada’s Big Four, hoping to win something back for the team, is Aphria (TSX:APHA) (NYSE:APHA). The NYSE’s most recent addition is giving a disappointing performance today. Down -1.33% and selling for $15.54, Aphria is no match for cannabis penny stocks competitor Isodiol International (CSE:ISOL), which is up a whopping 16.67% and selling for $2.45.
It’s clear that today’s losers are Canada’s Big Four—the cream of the crop of Canada’s cannabis industry. Why that is, is not clear, but investors seem to be hedging their bets on cannabis penny stocks instead.
Featured Image: Depositphotos/© eskaylim